Abstract:Background Vaspin is a newly-identified adipocytokine related to obesity and insulin sensitivity. However, its pathophysiologic role in humans remains largely unknown. The aim of our study was to investigate the relationship between serum vaspin level and glucose metabolism or obesity in Chinese adults.Methods A total of 123 subjects, including 84 subjects with normal glucose tolerance (NGT) and 39 subjects with diabetes, were enrolled in this study. Anthropometric parameters, abdominal fat areas, plasma glucose concentration, serum insulin, lipids, and vaspin level were measured in each participant.Results Serum vaspin concentration was significantly higher in diabetic patients than that in NGT subjects (592 (438-695) pg/ml vs 380 (294-517) pg/ml, P=0.020) in women. In all participants, age, fasting plasma glucose concentration (FPG), 2-hour post-load plasma glucose (PG2h), hemoglobin A1c (HbA1c) and high-density lipoprotein cholesterol (HDL-c) significantly increased from the lower tertile to the higher tertile of vaspin. Univariate linear regression analyses revealed that vaspin level was only positively correlated with age (beta=0.340, P=0.002) in NGT subjects. And vaspin was positively associated with FPG (beta=0.365, P=0.023), PG2h (beta=0.526, P=0.001), HbA1c (beta=0.388, P=0.016), and HDL-c (beta=0.353, P=0.027), while negatively with homeostasis model assessment of beta cell function (HOMA-beta) (beta=-0.361, P=0.024) in diabetic patients. In stepwise multivariate regression analyses, age was independently associated with circulating vaspin in NGT subjects, whereas PG2h was an independent predictor of vaspin in diabetic patients. In addition, there was no significant difference of serum vaspin level between men and women. And no significant correlations between vaspin and body fat indexes were detected.Conclusions Serum vaspin level is higher in diabetic patients than that in NGT subjects in women. Age predicts serum vaspin level in NGT subjects, while PG2h is independently associated with vaspin in diabetic patients. Chin Med J 2009;122(21):2530-2533

Review: Vaspin (SERPINA12) Expression and Function in Endocrine Cells

Vaspin in the pig ovarian follicles: expression and regulation by different hormones

Vaspin,obesity,and type 2 diabetes

Association of Serum Vaspin Concentration with Metabolic Disorders in Obese Individuals

Genetic dissection of serum vaspin highlights its causal role in lipid metabolism

Visceral Adipose Tissue-Derived Serine Protease Inhibitor: A Unique Insulin-Sensitizing Adipocytokine in Obesity

Progress in researches on the relationship of vaspin with obese and type 2 diabetes

Effect of adiponectin on obesity-linked diseases

Serum Vaspin Level in Relation to Postprandial Plasma Glucose Concentration in Subjects with Diabetes.

Vaspin Prevents Leptin-Induced Inflammation and Catabolism by Inhibiting the Activation of Nuclear Factor-Κb in Rat Chondrocytes

[Novel adipokines: links between obesity and atherosclerosis]

Serum levels of the adipokine vaspin in relation to metabolic and renal parameters

LRP1 is the cell-surface endocytosis receptor for vaspin in adipocytes

Changes and Clinical Significance of Serum Vaspin Levels in Patients with Type 2 Diabetes

Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases

Adipose-derived extracellular vesicles – a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome

Vaspin alleviates myocardial ischaemia/reperfusion injury via activating autophagic flux and restoring lysosomal function.

Role of Serum Vaspin in Progression of Type 2 Diabetes: a 2-Year Cohort Study.

Vaspin attenuates the apoptosis of human osteoblasts through ERK signaling pathway

Comparison of serum vaspin levels and vaspin expression in adipose tissue and smooth muscle tissue in pregnant women with and without gestational diabetes.

Association of serum vaspin concentration with insulin resistance in obese people